Maxwell Biosciences, Inc.
Austin, TX · CIK 0001907465 · Biotech · Private
Biostable antimicrobial peptide mimics (peptoids) designed to treat chronic suppurative otitis media by targeting biofilm persister cells
maxwellbiosciences.com →- Grants
- $257K
- 1 award
- Sector median: 1
- Raised
- $11M
- 2 Form D · Jul 2023
- 39 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 39
- 2 granted · 37 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Synthetic Antimicrobial Peptoids for Treatment of Chronic Suppurative Otitis Media | $256,538 | |
| Private capital raised | Form D · SEC | $10,850,247 | |
| Private capital raised | Form D · SEC | $25,000,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1600 | SYNACTIX PHARMACEUTICALS, INC. | — | — |
| 1601 | AllRock Bio | — | — |
| 1602 | TURTLETREE LABS INC. | — | — |
| 1603 | Maxwell Biosciences, Inc. | — | $11M |
| 1604 | Acer Therapeutics Inc. | — | $8.2M |
| 1605 | CeleCor Therapeutics, Inc. | — | $3.7M |
| 1606 | THERALINK TECHNOLOGIES, INC. | — | $2.6M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Annelise BarronDirector
- Barbara HolcombDirector
- Christopher JohnsDirector
- Joshua McClureDirector · Executive Officer · Promoter
- Kate McKinleyDirector
- Theodore MoskovitzDirector
- Praveen TyleDirector
Patents
- Antiviral Peptoid Compositionsgranted
- Pharmaceutical Compositions Featuring Mixtures Of Peptoids With And Without Terminal Aliphatic Moietiesapplication
- Lipopolysaccharide-binding Peptoids, And Compositions And Methods Of Use Thereofapplication
- Broad-spectrum Peptoids For Oral And Dental Hygiene, And Compositions And Methods Of Use Thereofapplication
- Broad-spectrum Peptoids For Treatment Or Prevention Of Wound Infections, And Compositions And Methods Of Use Thereofapplication
- Peptoids For Treating Filoviridae Infectionsapplication
- Substrates Modified With Peptoid-loaded Microgels For Resistance To Bacterial Colonizationapplication
- Surface Treatments Utilizing Immobilized Antimicrobial Peptide Mimicsapplication
- Surfactant Protein C Mimics Displaying Pathogen- Or Allergen-binding Moietiesapplication
- Modulation Of Gene Expression In A Human Bioreactorapplication
- Modulation Of Gene Expression In A Human Bioreactorgranted
- Peptoid-containing Personal Lubricantapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.